← Browse by Condition
Medical Condition

suicidal ideation

Total Trials
15
Recruiting Now
15
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for suicidal ideation sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — suicidal ideation Clinical Trials

How many clinical trials are currently recruiting for suicidal ideation?
ClinicalMetric currently tracks 15 actively recruiting clinical trials for suicidal ideation, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 15. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for suicidal ideation?
suicidal ideation research spans Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a suicidal ideation clinical trial?
Eligibility criteria for suicidal ideation trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
2
Top Sponsors
University Ghent 2 trials
University of Washington 1 trial
Jeff Bridge 1 trial
University of Texas Southwestern Medical Center 1 trial
Centre Hospitalier Régional d'Orléans 1 trial

Recruiting Clinical Trials

NCT06701006
Recruiting
Integrated Suicide Supports and Safety Planning for Youth
Enrollment
60 pts
Location
United States
Sponsor
University of Washington
View Trial →
NCT05390918
Recruiting
Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior
Enrollment
235 pts
Location
United States
Sponsor
Jeff Bridge
View Trial →
NCT07170657
Recruiting
Teen Recovery Through Inspiration, Support, and Empowerment
Enrollment
40 pts
Location
United States
Sponsor
University of Texas Southweste...
View Trial →
NCT07305701
Recruiting
Cohort Study on Medical Students' Mental Health
Enrollment
10,000 pts
Location
France
Sponsor
Centre Hospitalier Régional d'...
View Trial →
NCT06248268
Recruiting
Neuropsychological Patterns of Suicide Ideators and Suicide Attempters
Enrollment
180 pts
Location
Switzerland
Sponsor
University of Bern
View Trial →
NCT07125144
Recruiting
Piloting a Culturally Adapted Suicide Prevention for Black Students in Chicago
Enrollment
300 pts
Location
United States
Sponsor
University of Chicago
View Trial →
NCT07043231
Recruiting
Evaluation of Creative Materials Supporting Healthcare Professionals in Discussing Suicidality in Children and Adolescents
Enrollment
40 pts
Location
Belgium
Sponsor
University Ghent
View Trial →
NCT07063914
Recruiting
Stratified-Care School-Based Intervention for Adolescent Suicidal Ideation
Enrollment
60 pts
Location
Chile
Sponsor
Universidad de los Andes, Chil...
View Trial →
NCT07562191 Phase 2
Recruiting
Inhaled DMT for Major Depressive Disorder
Enrollment
140 pts
Location
Brazil
Sponsor
Universidade Federal do Rio Gr...
View Trial →
NCT07569198 Phase 2
Recruiting
Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)
Enrollment
120 pts
Location
Canada
Sponsor
Joshua Rosenblat
View Trial →
NCT05285111
Recruiting
Pilot of Reconnecting to Internal Sensations and Experiences in Undergraduates
Enrollment
200 pts
Location
United States
Sponsor
Auburn University
View Trial →
NCT05825820
Recruiting
Pilot Study of Health System/Community Partnership for Enhanced Outreach to Prevent Suicide Attempts
Enrollment
20 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT06776328
Recruiting
Co-creation of Tools for Children and Adolescents with Suicidal Thoughts And/or Behaviour
Enrollment
30 pts
Location
Belgium
Sponsor
University Ghent
View Trial →
NCT06614946
Recruiting
Improving Coping to Reduce Suicide Risk Following ED Discharge
Enrollment
120 pts
Location
United States
Sponsor
University of Michigan
View Trial →
NCT06315075
Recruiting
Dialectical Behavior Therapy for Adolescents With Self-harm and Suicidal Behavior- an Open Trial
Enrollment
140 pts
Location
Norway
Sponsor
Haukeland University Hospital
View Trial →

Related Conditions

suicide attempted (4) suicide (3) suicide attempt (2) major depressive disorder mdd (2) suicidal behavior (1) insomnia (1) anxiety (1) depression disorders (1) major depressive disorder (1) generalized anxiety disorder (1) alcoholism (1) marijuana abuse (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology